Hülya Dogan

Hülya Dogan

Auto-generated profile, based on publicly available information

Hülya Dogan

Institute of Animal Pathology, Vetsuisse Faculty, University of Bern, Bern, Switzerland

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 December 2025 in Oncogene
Verified
Journal Article
Open access
PDF file
HDHülya Dogan
Hülya Dogan
MLMartin Liptay
Martin Liptay
JBJoana S. Barbosa
Joana S. Barbosa
EGEwa Gogola
Ewa Gogola
ADAlexandra A. Duarte
Alexandra A. Duarte
SRSven Rottenberg
Sven Rottenberg
MDC1 is a key protein in DNA damage signaling. When DNA double-strand breaks (DSBs) occur, MDC1 localizes to the sites of DNA damage to promote the recruitment of other factors, including the 53BP1-mediated DSB repair pathway. By studying mechanisms of poly (ADP-ribose) polymerase inhibitor (PARPi) resistance in BRCA2; p53-deficient mouse mammary tumors, we identified a thus far unknown role of MDC1 in replication fork biology. Our results show that MDC1 localizes at active replication forks during normal DNA replication and regulates replication fork progression. It suppresses spontaneous fork reversal and regulates fork nucleolytic processing thereby promoting sensitivity to PARPi and cisplatin. In this way, MDC1 loss improves DNA damage tolerance and causes chemoresistance in BRCA1/2-deficient cells. We demonstrate that limiting MRE11 activity abolishes the reduced fork speed while MRE11 inhibition/depletion overcomes PARPi resistance in these cells. Overall, our data provides new insights into the role of MDC1 in replication fork progression that mediates PARPi- and cisplatin-induced DNA damage, in addition to its role in DSB repair.